Opioid weaning and eye markers

Not Applicable

• Conditions: Chronic Pain; Opioid dependency; Anaesthesiology - Pain management; Mental Health - Addiction

• Registration Number: ACTRN12621001714875
• Lead Sponsor: eCovery

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-15
• Study Completion: 2023-06-21
• Last Update Posted: 30 October 2023

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

1.Age over 18 years.
2.Male, or female. Women of childbearing age can be included
3.Must be on an oral morphine equivalent of more than 50mg for more than 3 months.
4.Patient must be deemed by the treating physician able to give informed consent.
5.The patient must be deemed able, physically and psychologically, to cooperate with the study.
6.Any prescribed opioids.

Exclusion Criteria

1.Pregnant.
2.Current substance misuse disorder. Patients on methadone and high dose buprenorphine (eg Suboxone) will be excluded. This is as the eCovery digital health application is not designed to help patients taking opioid substitution therapy for severe opioid use disorder.
3.Significant mental health disorder.
4.Do not have a mobile phone, or internet access that can use the eCovery application.
5.Do not have basic English speaking ability, as the eCovery application’s education is in English.
6.Do not wish to taper their opioids.
7.Any medical condition that would make tapering of opioids not possible at that stage.

Study & Design

• Study Type: Interventional
• Study Design: Not specified